/* */ PELVIPHARM - SPECIALIZED PRECLINICAL EXPERTISE in male and female sexual functions and diseases of the lower urinary tract
Receive our news

 
NEWS

January 11th - 2021

Best Wishes 2021

Best_Wishes_PVP2021_reduite.jpg

December 29th - 2020

Recently accepted paper in BMC Urol

Silodosin improves functional consequences of lower urinary tract obstruction secondary to benign prostate hypertrophy, a proof of concept study in the spontaneously hypertensive rat supplemented with testosterone

Assaly R, Faugeroux J, Laurin M, Compagnie S, Alexandre L, Giuliano F, Behr-Roussel D

BMC Urol, 2020 Aug 27;20(1):132

April 2nd - 2020

Recently accepted paper in Sexual Medecine

Extracorporeal Shock Waves Therapy Delivered by Aries Improves Erectile Dysfunction in Spontaneously Hypertensive Rats Through Penile Tissue Remodeling and Neovascularization

Assaly R, Giuliano F, Clement P, Laurin M, Favier M, Teo P, Bernabe J, Alexandre L, Behr-Roussel D

Sexual Medecine - 2019 : Dec;7(4):441-450 

March 29th - 2020

Press Release DICOT

Dicot_press_1.JPG

Dicot_press_2.JPG

January 17th - 2020

Best Wishes 2020

VOEUX_PVP_2020_Web.jpg

November 25th - 2019

BioFIT in Marseille, December 2019

Pelvipharm will be represented by Rana Assaly at the next BioFIT in Marseille, December 10-11 2019.
We warmly invite you to take this opportunity to learn more about our services.

If you’d like to set up a specific meeting at any time throughout the conference, please email contact@pelvipharm.comand we will be happy to assist you.

BIOFIT_2019.png

Page 1 / 20     Previous      1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  Next 
SITEMAP
TEL +331 704 293 39
FAX + 331 704 295 10
LEGAL